Somatometric and Bioimpedance Parameters in the Assessment of Physical Development in Patients with Esophageal Cancer
- Authors: Startsev S.S.1,2, Gorbunova E.A.3,4, Danilova A.A.3, Medvedeva N.N.3, Zukov R.A.3,4
-
Affiliations:
- Sakhalin Regional Clinical Oncology Center
- Pacific State Medical University
- Professor Voino-Yasenetsky Krasnoyarsk State Medical University
- Kryzhanovsky Krasnoyarsk Regional Clinical Oncology Dispensary
- Issue: Vol 163, No 2 (2025)
- Pages: 145-155
- Section: Original Study Articles
- Submitted: 05.11.2024
- Accepted: 14.02.2025
- Published: 23.06.2025
- URL: https://j-morphology.com/1026-3543/article/view/641577
- DOI: https://doi.org/10.17816/morph.641577
- EDN: https://elibrary.ru/WKNIYP
- ID: 641577
Cite item
Abstract
BACKGROUND: Esophageal cancer is an oncological disease characterized by an extremely unfavorable course and prognosis. The high mortality rate associated with esophageal cancer underscores the importance of preventive screening programs in population and the need to expand the range of known risk factors for this disease. In this context, the study of physical development characteristics in patients with esophageal cancer is of particular interest.
AIM: To investigate somatometric and bioimpedance characteristics of physical development in patients with esophageal cancer.
METHODS: Anthropometric and bioimpedance measurements were conducted in 86 patients diagnosed with esophageal cancer. Body height and weight, shoulder and hip width, waist and hip circumference were measured. Body mass index and the sexual dimorphism index according to J.M. Tanner were calculated. Bioimpedance analysis was performed using the ABC01-036 hardware-software system (Medass, Russia). Body composition and phase angle were assessed. The phase angle of impedance reflects the intensity of metabolic processes in the body and is used as a prognostic indicator in oncological diseases. Statistical processing of the obtained data was performed using descriptive statistics methods. The Shapiro–Francia, Kolmogorov–Smirnov, Kruskal–Wallis, Fisher’s F-test, and Pearson’s chi-square test were used. Differences were considered statistically significant at p < 0.05.
RESULTS: Normal body weight was noted in most women with squamous cell carcinoma of the esophagus and in men with esophageal adenocarcinoma. Among male patients with esophageal cancer, the mesomorphic body type predominated, with a shift toward gynecomorphy (p = 0.001). A mesomorphic somatotype prevailed among female patients (p = 0.001). No statistically significant differences in bioimpedance parameters were found among patients with esophageal cancer depending on somatotype. Decreased phase angle values relative to the reference range established for the Russian population were recorded with equal frequency in patients with esophageal cancer, regardless of disease stage, which allows this parameter to be considered a potential marker of poor prognosis.
CONCLUSION: Body weight deficiency is not typical for patients with esophageal adenocarcinoma. Overall, patients with esophageal cancer tend to exhibit a mesomorphic somatotype, with a shift toward gynecomorphy in men, as well as decreased phase angle values regardless of disease stage.
Full Text

About the authors
Sergey S. Startsev
Sakhalin Regional Clinical Oncology Center; Pacific State Medical University
Email: sakhstar2010@mail.ru
ORCID iD: 0009-0003-0749-0778
SPIN-code: 6223-7575
Russian Federation, Yuzhno-Sakhalinsk; Vladivostok
Ekaterina A. Gorbunova
Professor Voino-Yasenetsky Krasnoyarsk State Medical University; Kryzhanovsky Krasnoyarsk Regional Clinical Oncology Dispensary
Author for correspondence.
Email: opium-100@yandex.ru
ORCID iD: 0000-0002-5297-5980
SPIN-code: 8525-7253
MD, Cand. Sci. (Medicine)
Russian Federation, Krasnoyarsk; KrasnoyarskAnna A. Danilova
Professor Voino-Yasenetsky Krasnoyarsk State Medical University
Email: anya.danilova.02@list.ru
ORCID iD: 0009-0006-1412-8066
SPIN-code: 4287-1951
Russian Federation, Krasnoyarsk
Nadezhda N. Medvedeva
Professor Voino-Yasenetsky Krasnoyarsk State Medical University
Email: medvenad@mail.ru
ORCID iD: 0000-0002-7757-6628
SPIN-code: 6144-1780
MD, Dr. Sci. (Medicine), Professor
Russian Federation, KrasnoyarskRuslan A. Zukov
Professor Voino-Yasenetsky Krasnoyarsk State Medical University; Kryzhanovsky Krasnoyarsk Regional Clinical Oncology Dispensary
Email: zukov_rus@mail.ru
ORCID iD: 0000-0002-7210-3020
SPIN-code: 3632-8415
MD, Dr. Sci. (Medicine), Professor
Russian Federation, Krasnoyarsk; KrasnoyarskReferences
- Bray F, Laversanne M, Sung H, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74(3):229–263. doi: 10.3322/caac.21834 EDN: FRJDQH
- Lander S, Lander E, Gibson MK. Esophageal cancer: Overview, risk factors, and reasons for the rise. Curr Gastroenterol Rep. 2023;25(11):275–279. doi: 10.1007/s11894-023-00899-0 EDN: ZCSNMO
- Domper Arnal MJ, Ferrández Arenas Á, Lanas Arbeloa Á. Esophageal cancer: Risk factors, screening and endoscopic treatment in Western and Eastern countries. World J Gastroenterol. 2015;21(26):7933–7943. doi: 10.3748/wjg.v21.i26.7933
- Waters JK, Reznik SI. Update on management of squamous cell esophageal cancer. Curr Oncol Rep. 2022;24(3):375–385. doi: 10.1007/s11912-021-01153-4 EDN: SFHQSO
- Ajani JA, D’Amico TA, Bentrem DJ, et al. Esophageal and esophagogastric junction cancers, Version 2.2023, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2023;21(4):393–422. doi: 10.6004/jnccn.2023.0019 EDN: WHZQFG
- Thrift AP. Global burden and epidemiology of Barrett oesophagus and oesophageal cancer. Nat Rev Gastroenterol Hepatol. 2021;18(6):432–443. doi: 10.1038/s41575-021-00419-3 EDN: NPDXUE
- Uhlenhopp DJ, Then EO, Sunkara T, Gaduputi V. Epidemiology of esophageal cancer: update in global trends, etiology and risk factors. Clin J Gastroenterol. 2020;13(6):1010–1021. doi: 10.1007/s12328-020-01237-x EDN: ASXUOY
- Gladilina IA, Tryakin AA, Zakhidova FO, et al. Esophageal cancer: epidemiology, risk factors and diagnostic methods. Journal of oncology: diagnostic radiology and radiotherapy. 2020;3(1):69–76. (In Russ.) doi: 10.37174/2587-7593-2020-3-1-69-76 EDN: DUVSPG
- Zyuzyukina AV, Gasymly DDK, Komissarova VA, et al. Anthropometric and topometric characterization of patients with breast cancer. Russian Journal of Oncology. 2021;26(3):77–84. (In Russ.) doi: 10.17816/onco107114 EDN: ISNXQQ
- Khusnutdinov RM, Sitdikov AM, Fatkullov IR, et al. Comparative analysis of the functional state of the body of athletes and non-athletes according to anthropometry, morphology and IPC. Scientific notes of the P.F. Lesgaft University. 2023;12(226):208–213. (In Russ.) EDN: WQVFSM
- Orlov VA, Razumov AN, Strizhakova OV, Fudin NA. Human health - an “activity-based” approach and quantitative measurement. Journal of new medical technologies, eEdition. 2022;16(5):64–70. (In Russ.) doi: 10.24412/2075-4094-2022-5-2-2 EDN: DEGMAA
- Sakibaev KSh, Nikityuk DB, Nikolaev DV, et al. Experience in the use of bioimpedance measurement to assess the composition of the human body. Bulletin of Medicine and Education. 2021;(2):137–146. (In Russ.) EDN: FIXXIU
- Kostyuchenko LN, Kruglov AD, Kostyuchenko MV, Lychkova AE. Method of bioimpedancemetria for assessing metabolism in colorectal cancer and pancreatic cancer. Medical Alphabet. 2019;4(38):54–58. (In Russ.) doi: 10.33667/2078-5631-2019-4-38(413)-54-58 EDN: UVYLFM
- Kamalova AA, Safina ER, Gaifutdinova AR. Body composition in children with inflammatory bowel diseases. Practical medicine. 2022;20(1):67–73. (In Russ.) doi: 10.32000/2072-1757-2022-1-67-73 EDN: WYPJES
- Zharikov YuO, Kovaleva ON, Maslennikov RV, Gadzhiakhmedova AN. Nutritional status of patients with cirrhosis of the liver. Chronos. 2022;7(11(73)):30–32. (In Russ.) doi: 10.52013/2658-7556-73-11-8 EDN: SDTULQ
- Rudnev SG, Soboleva NP, Sterlikov SA. Bioimpedance study of the body composition in the Russian population. Moscow: Federal Research Institute for Health Care Organization and Information; 2014. (In Russ.) ISBN: 5-94116-018-6 EDN: TDSYFP
- Hui D, Moore J, Park M, et al. Phase angle and the diagnosis of impending death in patients with advanced cancer: Preliminary findings. Oncologist. 2019;24(6):e365–e373. doi: 10.1634/theoncologist.2018-0288
- Miura T, Matsumoto Y, Kawaguchi T, et al. Low phase angle is correlated with worse general condition in patients with advanced cancer. Nutr Cancer. 2019;71(1):83–88. doi: 10.1080/01635581.2018.1557216
- Koyanagi YN, Matsuo K, Ito H, et al. Body mass index and esophageal and gastric cancer: A pooled analysis of 10 population-based cohort studies in Japan. Cancer Sci. 2023;114(7):2961–2972. doi: 10.1111/cas.15805 EDN: EYZUSN
- Loehrer EA, Giovannucci EL, Betensky RA, et al. Prediagnostic adult body mass index change and esophageal adenocarcinoma survival. Cancer Med. 2020;9(10):3613–3622. doi: 10.1002/cam4.3015 EDN: ZHZJBK
- Li S, Xie K, Xiao X, et al. Correlation between sarcopenia and esophageal cancer: a narrative review. World J Surg Oncol. 2024;22(1):27. doi: 10.1186/s12957-024-03304-w EDN: DEIGGP
- Jogiat UM, Bédard ELR, Sasewich H, et al. Sarcopenia reduces overall survival in unresectable oesophageal cancer: a systematic review and meta-analysis. J Cachexia Sarcopenia Muscle. 2022;13(6):2630–2636. doi: 10.1002/jcsm.13082 EDN: GAERDW
- Boshier PR, Heneghan R, Markar SR, et al. Assessment of body composition and sarcopenia in patients with esophageal cancer: a systematic review and meta-analysis. Dis Esophagus. 2018;31(8). doi: 10.1093/dote/doy047
- Tanner JM. Childhood epidemiology. Physical development. Br Med Bull. 1986;42(2):131–138. doi: 10.1093/oxfordjournals.bmb.a072110 EDN: ILSADT
- Sindeyeva LV, Rudnev SG. Characteristic of the age and sex-reated variability of the Heath-Carter somatotype in adults and possibility of its bioimpedance assessment (as exemplified by Russian population of Eastern Siberia). Morphology. 2017;151(1):77–87 (In Russ.) EDN: YKUYXN
- van der Schaaf MK, Tilanus HW, van Lanschot JJ, et al. The influence of preoperative weight loss on the postoperative course after esophageal cancer resection. J Thorac Cardiovasc Surg. 2014;147(1):490–495. doi: 10.1016/j.jtcvs.2013.07.072
- Gu WS, Fang WZ, Liu CY, Pan KY, Ding R, Li XH, Duan CH. Prognostic significance of combined pretreatment body mass index (BMI) and BMI loss in patients with esophageal cancer. Cancer Manag Res. 2019;11:3029–3041. doi: 10.2147/CMAR.S197820
Supplementary files
